Mark Alan Goldberg - 29 Mar 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: Director
Issuer ticker: GLYC
Reported as of: 29 Mar 2024
Net transaction value: +$13,752
SEC form: 4
Accepted by SEC: 02 Apr 2024, 16:05:22 UTC
Prior SEC filing: 12 Feb 2024
Next SEC filing: 01 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, Attorney-in-Fact

Key filing fact

Mark Alan Goldberg filed Form 4 for GLYCOMIMETICS INC (GLYC) on 02 Apr 2024.

Key facts

This page summarizes Mark Alan Goldberg's Form 4 filing for GLYCOMIMETICS INC (GLYC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2024, 16:05.

Change

Previous filing in this sequence was filed on 12 Feb 2024.
Current net transaction value: +$13,752.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLYC transaction

Common Stock

Award

Transaction value: $13,752
Shares: +4,584
Change %: +23%
Price: $3.00
Shares after: 24,828
Date: 29 Mar 2024
Ownership: Direct
Footnotes: F1

GLYC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,497
Date: 29 Mar 2024
Ownership: By family trusts

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $13,750.